SUPERNUS PHARMACEUTICALS INC (SUPN) Institutional Ownership

SUPN is currently held by 3 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $96.25M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $88.14M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's SUPN position is now estimated to be worth approximately $74.31M, representing an estimated loss of -15.69% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Third Avenue Management, Sequoia Financial Advisors, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward SUPERNUS PHARMACEUTICALS INC (SUPN).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20263$96,249,1071,862,045
Q4 20252$95,524,1451,922,015
Q3 20252$92,287,5691,930,115
Q2 20252$58,148,5681,844,815
Q1 20252$58,138,2921,775,215
Q4 20242$64,661,8551,788,215
Q3 20242$59,806,8261,918,115
Q2 20242$50,135,9211,874,240
Q1 20242$5,493,4231,492,939
Q4 20232$4,662,1021,538,139
Q3 20232$3,312,3531,554,971
Q2 20232$2,060,8631,563,384